1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS
@article{Lawitz20091055AA,
title={1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS},
author={E. Lawitz and M. Rodr{\'i}guez-Torres and M. Demicco and T. Nguyen and E. Godofsky and J. Appleman and M. Rahimy and C. Crowley and J. Freddo},
journal={Journal of Hepatology},
year={2009},
volume={50}
}Topics from this paper
35 Citations
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
- Medicine
- European Journal of Medicinal Chemistry
- 2021
- 1
Direct-acting antivirals for chronic hepatitis C.
- Medicine
- The Cochrane database of systematic reviews
- 2017
- 132
- PDF
A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects
- Medicine
- Clinical pharmacology in drug development
- 2014
- 2
Hepatitis C virus-specific directly acting antiviral drugs.
- Medicine
- Current topics in microbiology and immunology
- 2013
- 34
- PDF
New therapeutic strategies in HCV: polymerase inhibitors
- Medicine
- Liver international : official journal of the International Association for the Study of the Liver
- 2013
- 53
RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs.
- Biology, Medicine
- Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
- 2013
- 21
Treatment of chronic hepatitis C: current and future.
- Medicine
- Current topics in microbiology and immunology
- 2013
- 89